Biogen Canada is a biotechnology company that focuses on the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases. The company is known for its work in areas such as multiple sclerosis (MS), Alzheimer’s disease, spinal muscular atrophy (SMA), and other neurological disorders.
Services: Biogen Canada’s services include research and development of innovative therapies and drugs for neurological conditions, manufacturing and commercialization of approved medications, and support and educational resources for patients and healthcare professionals.
Employees and Offices: Biogen Canada’s head office is located in Toronto. Over 200 of the company’s 9,000 employees work in Canada.
Types of Jobs: Biogen employs a diverse workforce, including research scientists and biotechnologists, regulatory affairs professionals, manufacturing and supply chain specialists, sales and marketing teams, and corporate functions such as finance, human resources, and IT.
Brief History: Biogen was founded in 1978 by a group of scientists, including Phillip Sharp and Walter Gilbert, who were Nobel Prize winners in the field of genetics. The company started with a focus on developing treatments for MS and grew steadily over the years, expanding its portfolio of therapies. One of its significant breakthroughs came with the introduction of “Avonex,” an interferon beta-1a therapy for relapsing forms of MS, which became one of the leading medications for the...
"The election poster for a Reform Party candidate running for Seoul's Gwangjin District Council is written entirely in Chinese. Is this China?" says part of a Korean-language Facebook post shared ...